Praxis Precision Medicines (PRAX) total debt

Total debt · fiscal 2025
$110.00K

Praxis Precision Medicines (PRAX) carried total debt of $110.00K at the end of fiscal 2025 (December 31, 2025). That is 92.0% lower than the $1.37M of fiscal 2024. Figures as of 18 Nov 2026, 07:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$110.00K
Change on fiscal 2024
−92.0%
Highest on record
$3.50Mfiscal 2022
Lowest on record
$110.00Kfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Praxis Precision Medicines total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $3.50M in fiscal 2022 and the lowest $110.00K in fiscal 2025.

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Praxis Precision Medicines total debt, year by year

Praxis Precision Medicines (PRAX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$110.00K 92.0% down0.0×
2024$1.37M 45.1% down0.0×
2023$2.50M 28.7% down0.0×
2022$3.50M—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

Total debt at health care companies of similar size

Total debt of Praxis Precision Medicines and comparable companies
CompanyTotal debtFiscal year
Oscar Health OSCR$430.10M2025
TG Therapeutics TGTX$253.71M2025
Praxis Precision Medicines PRAX$110.00K2025
Twist Bioscience TWST$94.99M2026
Protagonist Therapeutics PTGX$10.32M2025
Krystal Biotech KRYS$9.34M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on PRAX

Praxis Precision Medicines, figure by figure

Praxis Precision Medicines (PRAX) overview: price, valuation and scorecardAll health care companies by market value

Praxis Precision Medicines total debt: questions and answers

How much debt does Praxis Precision Medicines have?

Praxis Precision Medicines (PRAX) carried total debt of $110.00K at the end of fiscal 2025 (December 31, 2025). That is 92.0% lower than the $1.37M of fiscal 2024.

What are the highest and lowest total debt figures on record for Praxis Precision Medicines?

Across the 4 fiscal years on record (2022–2025), the highest was $3.50M in fiscal 2022 and the lowest $110.00K in fiscal 2025.

How does Praxis Precision Medicines's debt compare with its equity?

Total debt was 0.0× shareholders' equity at the end of fiscal 2025.

How is Praxis Precision Medicines's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Praxis Precision Medicines (PRAX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/PRAX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.